Prospective clinical trial about physical activity in fibromyalgia;Prospektive klinische pilotstudie zur wirksamkeit konditionierender maßnahmen bei patienten mit fibromyalgie

Aktuelle Rheumatologie

Volumn 32, Issue 1, 2007, Pages 27-33

  Uhlemann, Christine ^a   Strobel, I ^a   Muller Ladner U ^b   Lange, U ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Fibromyalgia; Physical activity; Physiotherapeutic interventions

Indexed keywords

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDURANCE; ERGOMETRY; FEMALE; FIBROMYALGIA; FITNESS; FOLLOW UP; HUMAN; MALE; PAIN ASSESSMENT; PHYSICAL ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TRAINING; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34247568442     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-962879     Document Type: Article

References (33)

1. Adler GK, Kinsley BT, Hurwitz S et al. Reduced hypothalamic-pituitary and sympathoarenal response to hypoglycaemia in women with fibromyalgia syndrome. Am J Med 1999; 106: 534-543
2. Anderberg UM, Uvnäs-Moberg K. Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 2000; 59: 373-379
3. Bengtsson A, Henriksson KG, Larsson J. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 1986; 29: 817-821
4. Bennett RM, Clark SR, Campbell SM et al. Low levels of somatomedin C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 1992; 35: 1113-1116
5. Bennett RM, Burckhardt CS, Clark SR et al. Group treatment of fibromyalgia: a 6 month outpatient program. J Rheumatol 1996; 23: 521-528
6. Bennett RM. Fibromyalgia review. J Muscoloskeletal Pain 2001; 9: 91-110
7. Branco J, Atalaia A, Paiva T. Sleep cycles and alpha-delta sleep in fibromyalgia syndrome. J Rheumatol 1994; 21: 1113-1117
8. Chase TN, Murphy DL. Serotonin and central nervous system function. Ann Rev Pharmacol Toxicol 1983; 13: 181-197
9. Crofford LJ. The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol 1998; 57: 67-71
10. Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Baillières Best Pract Res Clin Rheumatol 2003; 17: 685-701
11. Henriksson KG. Fibromyalgia - from syndrome to disease. Overview of pathogenetic mechanisms. J Rehabil Med 2003; 41: 89-94
12. Leiber B. Die klinischen Syndrome. 7. Auflage. München: Urban und Schwarzenberg, 1990
13. Mannerkorpi K, Ahlmén M, Ekdahl C. Six- and 24 month follow-up of pool exercise therapy and education for patients with fibromyalgia. Scand J Rheumatol 2002; 31: 306-310
14. Mannerkorpi K, Iverson MD. Physical exercise in fibromyalgia and related syndromes. Baillières Best Pract Res Clin Rheumatol 2003; 17: 629-647
15. McCain GA, Bell DA, Mai FM et al. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988; 31: 1135-1141
16. Mengshoel AM, Komnaes HB, Forre O. The effects of twenty weeks of physical futness training in female patients with fibromyalgia. Clin Exp Rheumatol 1992; 10: 345-349
17. Moldofsky H, Scarisbrick P, England R et al. Musculosceletal symptoms and non-REM sleep disturbace in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med 1975; 37: 341-351
18. Moldofsky H. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system, serotonin and pain. Adv Neurol 1982; 33: 51-57
19. Pongratz DE. Fibromyalgie: therapeutische Möglichkeiten. Arzneimitteltherapie 2006; 1: 13-16
20. Russell IJ. Advances in Fibromyalgia: Possible Role for Central Neurochemicals. Am J Med Sci 1998; 315: 377-384
21. Schochat T, Beckman C. Soziodemographie, Risikofaktoren und Reproduktionsanamnese bei Fibromyalgie. Ergebnisse einer bevblkerungsbezogenen Studie. Z Rheumatol 2003; 62: 46-59
22. Simms RW. Fibromyalgia syndrome: current concepts in pathophysiology, clinical features and management. Arthritis Care Res 1996; 9: 315-328
23. Sprotte G. Ansätze zur Pathogenese und Therapie des Fibromyalgie-syndroms. Forsch Komplementärmed Klass Naturheilkd 2002; 9: 308-310
24. Uhlemann C. Physiotherapeutische Möglichkeiten bei der Intervention des Fibromyalgiesyndroms. Forsch Komplementärmed Klass Naturheilkd 2002; 9: 3010-3011
25. Uhlemann C. Physikalische Schmerztherapie, Naturheilverfahren, Akupunktur und traditionelle chinesische Medizin. In: Schiltenwolf M, Henningsen P (Hrsg). Orthopädische Schmerztherapie. Köln: Deutscher Ärzteverlag, 2006: 240-285
26. Van Santen M, Bolwijn P, Landewe R et al. A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia. Rheumatol 2002; 29: 575-581
27. Watkins LR, Wierteiak EP, Goehler LE et al. Characterization of cytokine-induced hyperalgesia. Brain Res 1994; 651: 15-26
28. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000; 51: 29-57
29. Watkins LR, Milligan ED, Maier SF. Spinal cord glia: New players in pain. Pain 2001; 93: 201-205
30. Wigers SH, Stiles TC, Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. Scand J Rheumatol 1996; 25: 77-86
31. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology. Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 160-172
32. Wolfe F, Anderson J, Harkness D et al. Health status and disease severity in fibromyalgia. Arthritis Rheum 1997; 40: 1571-1579
33. Wolfe F, Russell IJ, Vipraio GA et al. Serotonin levels, pain threshhold and FMS. J Rheumatol 1997; 24: 555-559